Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer
- 1 January 2010
- journal article
- review article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 6 (1), 25-35
- https://doi.org/10.2217/fon.09.133
Abstract
A review of the literature demonstrated that clinical evaluation cannot be used to determine ‘complete response’. The different classification systems of the histopathologic response grading after neoadjuvant radiochemotherapy of esophageal carcinoma are summarized in this report. A systematic review of studies analyzing preoperative chemoradiation of squamous cell carcinoma (SCC) or adenocarcinoma (AC) of the esophagus demonstrated no significant difference in pathologic complete response (pCR) rates between the AC and SCC studies. Analyzing only the applied dose of radiation demonstrated that patients with AC required a higher dose than patients with SCC to achieve complete response. Incorporating chemotherapy administration does not markedly change the difference in required radiation dose. However, when the tumor does respond, the rate of pCR with increasing dosage of chemoradiotherapy increases more rapidly in AC patients than in SCC patients.Keywords
This publication has 58 references indexed in Scilit:
- Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal CancerAnnals of Surgery, 2008
- Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal CancerJournal of Clinical Oncology, 2007
- Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalitiesThe Lancet Oncology, 2007
- Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysisThe Lancet Oncology, 2007
- Endoscopic Ultrasound Restaging After Neoadjuvant Chemotherapy in Esophageal CancerThe American Journal of Gastroenterology, 2006
- Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysisSurgery, 2005
- Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysisGut, 2004
- Neoadjuvant therapy for oesophagogastric cancerBritish Journal of Surgery, 2004
- Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapyBritish Journal of Surgery, 2003
- Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinomaCancer, 1997